Exploring the effects of a brief therapy program on suicidal behavior and thoughts
Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy ASSIP on Neuropsychological Correlates and Psychological Process Factors (NePsyASSIP HT) - Project 2
This study is testing a brief therapy program to see if it can help people who have tried to commit suicide feel better compared to those who just get standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 156 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Bern Academic / other |
| Locations | 1 site (Bern) |
| Trial ID | NCT06263712 on ClinicalTrials.gov |
What this trial studies
This study investigates the psychological patterns that differentiate individuals who have attempted suicide from those who only have suicidal thoughts. Participants with a history of suicide attempts will be randomly assigned to receive either the Attempted Suicide Short Intervention Program (ASSIP) or standard care plus a resource interview. The study aims to assess the effectiveness of ASSIP in modulating neuropsychological factors associated with suicidal behavior. Conducted at the University Hospital of Psychiatry and Psychotherapy in Bern, Switzerland, the research will also evaluate the feasibility of home treatment through this intervention.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a history of at least one suicide attempt.
Not a fit: Patients with serious cognitive impairments or psychotic disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved therapeutic approaches for individuals at risk of suicide.
How similar studies have performed: Previous studies have shown that brief interventions like ASSIP can be effective, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria for Project 2: Subjects fulfilling the following inclusion criteria are eligible for the study: * Informed consent as documented by signature * Age ≥ 18 years * At least one previous suicide attempt * Willingness to attend the ASSIP brief therapy * Owns a smartphone Exclusion Criteria for Project 2: The presence of any one of the following exclusion criteria will lead to exclusion of the subject: * Serious cognitive impairment * Any psychotic disorder * Any current medication, which substantially impairs the attention span, reaction, rate or any other relevant cognitive functions * Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study)
Where this trial is running
Bern
- University Hospital of Psychiatry and Psychotherapy, University of Bern — Bern, Switzerland (Recruiting)
Study contacts
- Principal investigator: Anja C. Gysin-Maillart, PhD — University of Bern, University Hospital of Psychiatry, Translational Research Center
- Study coordinator: Anja C. Gysin-Maillart, PhD
- Email: anja.gysin-maillart@unibe.ch
- Phone: +41 (0) 31 632 88 11
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.